Insider trade

Palvella Therapeutics (PVLA): Chief Operating Officer exercised options on 2,148 shares

Kathleen Goin, Chief Operating Officer at Palvella Therapeutics, reported an option exercise of 2,148 shares.

2,148
Shares · @ $9.08

Traded: Oct 21, 2026
Filed: Oct 23, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Oct 12, 2026Insider · 1 personInsiders: 5 sales (~$1.8M)
Oct 13, 2026Insider · 1 personInsiders: 6 sales (~$935K)
Oct 14, 2026Insider · 1 personInsiders: 6 sales (~$886K)
Oct 21, 2026Insider · 1 personInsiders: 3 sales (~$537K)

What came next

Oct 28, 20265% stakeJennison Associates LLC reported a passive stake (13G) of 7.7%
Nov 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
Nov 10, 2026Insider · 1 personInsiders: 7 sales (~$1.0M)
Nov 11, 2026Insider · 1 personInsiders: 6 sales (~$1.0M)

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Palvella Therapeutics

For Palvella Therapeutics, OQRO holds 36 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its PVLA page.

Other recent filings by Kathleen Goin, Chief Operating Officer

The full history of Kathleen Goin, Chief Operating Officer is on the profile page.

How this filing works

Explore the data

Other disclosures at Palvella Therapeutics

Everything OQRO holds on this company is on its PVLA page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data